Anti-Ro52 antibody is highly prevalent and a marker of better prognosis in patients with ovarian cancer

Publication date: Available online 8 July 2021Source: Clinica Chimica ActaAuthor(s): Dimitrios P. Bogdanos, Athanasios Gkoutzourelas, Vasilios Papadopoulos, Christos Liaskos, Eleni Patrikiou, Christina Tsigalou, Athanasios Sarantziotis, John Hajiioannou, Thomas Scheper, Wolfgang Meyer, Lazaros I. Sakkas, Christos Papandreou
Source: Clinica Chimica Acta - Category: Laboratory Medicine Source Type: research